Work

23P Engineered chemotherapy resistant γδ T-cells with combinatorial chemotherapies can enhance tumor cell immunogenicity and killing

Year: 2022

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2022.01.031

Authors: K.M. Rochlin, A. Jones, L. Ding, L. Lamb, A. Hjelmeland

Institutions: University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4221017239

FWCI:

Cites:

Cited by:

Related to: 10